EQUASENS (ex-PHARMAGEST INTERACTIVE) : Chiffre d’affaires du 1er semestre 2022
August 03, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 3 août 2022 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires du 1er semestre 2022 Progression de +10,3% à 103,57 M€. A périmètre comparable (hors acquisition de PROKOV...
EQUASENS (ex-Pharmagest Interactive): H1 2022 Revenue
August 03, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 3 August 2022 - 6:00 p.m. (CET) PRESS RELEASE H1 2022 Revenue Up 10.3% to €103.57m. Like-for-like (excl. the PROKOV EDITIONS acquisition), Group revenue grows 7.68% to €101.11m....
EQUASENS (ex - PHARMAGEST INTERACTIVE) : Le Groupe complète 3 prises de participation majoritaire
July 28, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 28 juillet 2022 - 18h00 (CET) COMMUNIQUE DE PRESSE LE GROUPE EQUASENS (anciennement PHARMAGEST INTERACTIVE) COMPLETE 3 PRISES DE PARTICIPATION MAJORITAIRE Le Groupe Equasens...
Equasens Group (ex Pharmagest Interactive): Complition of three majority acquisitions
July 28, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 28 July 2022- 6:00 p.m. (CET) PRESS RELEASE EQUASENS GROUP (formerly PHARMAGEST INTERACTIVE)COMPLETES THREE MAJORITY ACQUISITIONS Equasens Group now owns: 76.11% of CAREMEDS...
EQUASENS (ex PHARMAGEST INTERACTIVE) : BILAN SEMESTRIEL S1-2022 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT
July 21, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 21 juillet 2022 - 18h00 (CET) COMMUNIQUE DE PRESSE BILAN SEMESTRIEL S1-2022 DU CONTRAT DE LIQUIDITECONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT Au titre du contrat de...
EQUASENS (ex Pharmagest Interactive): H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH THE BROKERAGE FIRM GILBERT DUPONT
July 21, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 21 July 2022 – 6:00 p.m. (CET) PRESS RELEASE H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENTWITH THE BROKERAGE FIRM GILBERT DUPONT Under the liquidity agreement administered...
EQUASENS (ex Pharmagest Interactive) : RESULTAT DU VOTE DES RESOLUTIONS PRESENTEES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE DU 28 JUIN 2022
July 06, 2022 13:01 ET
|
EQUASENS
Villers-lès-Nancy, le 6 juillet 2022 - 19h00 (CET) COMMUNIQUE DE PRESSE RESULTAT DU VOTE DES RESOLUTIONS PRESENTEESA L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE DU 28 JUIN 2022 Nombre d’actions...
EQUASENS (Ex Pharmagest Interactive): RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 28 JUNE 2022
July 06, 2022 13:01 ET
|
EQUASENS
Villers-lès-Nancy, 6 July 2022 - 7:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS'...
EQUASENS (ex Pharmagest Interactive) intègre le nouveau segment Euronext TECH LEADERS
June 27, 2022 01:00 ET
|
EQUASENS
Villers-lès-Nancy, le 27 juin 2022 - 07h00 (CET) COMMUNIQUE DE PRESSE EQUASENS (anciennement PHARMAGEST INTERACTIVE) intègre le nouveau segment Euronext TECH LEADERS Le Groupe Equasens (Euronext...
EQUASENS (ex Pharmagest Interactive) joins Euronext’s new TECH LEADERS segment
June 27, 2022 01:00 ET
|
EQUASENS
Villers-lès-Nancy, 27 June 2022 - 7:00 a.m. (CET) PRESS RELEASE EQUASENS (formerly PHARMAGEST INTERACTIVE)joins Euronext’s new TECH LEADERS segment ...